Dr. Thomas is a diagnostic radiologist in the Body Imaging division of Diagnostic Imaging at Moffitt Cancer Center. Dr. Thomas has expertise in interpreting imaging studies of the chest, abdomen and pelvis across multiple modalities, including CT scan, ultrasound, and MRI. Dr. Thomas completed undergraduate training at the Florida State University, followed by medical training at the University of South Florida Morsani College of Medicine. Dr. Thomas continued at USF Morsani College of Medicine for Diagnostic Radiology residency training, where she served as chief resident. She also completed her fellowship training in body imaging at USF and joined Moffitt following fellowship in 2014. She has a passion for educating the next generation of physician, including medical students, residents and fellows. Dr. Thomas holds an appointment to the USF Department of Radiology where she serves as a core faculty member of the USF diagnostic radiology residency program and also serves as the Chair of Graduate Medical Education for Moffitt Cancer Center. Dr. Thomas is a member of several professional radiology organizations, including the American College of Radiology, Radiologic Society of North America, and the Society of Abdominal Radiology.
Education & Training
University of South Florida Morisani College of Medicine - Body Imaging
University of South Florida Morisani College of Medicine - Diagnostic Radiology
University of South Florida Morisani College of Medicine - MD
Thomas KL, Zafar H, Parikh P, Korngold E, Canon CL, Sadowski E. Representation of women among leadership and honorees within the Society of Abdominal Radiology, past and present. Abdom Radiol (NY). 2021 Jan. Pubmedid: 33452899.
Anaya DA, Dogra P, Wang Z, Haider M, Ehab J, Jeong DK, Ghayouri M, Lauwers GY, Thomas K, Kim R, Butner JD, Nizzero S, Ramírez JR, Plodinec M, Sidman RL, Cavenee WK, Pasqualini R, Arap W, Fleming JB, Cristini V. A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases. Cancers (Basel). 2021 Jan.13(3). Pubmedid: 33503971. Pmcid: PMC7866038.
Parsee AA, Thomas KL, Ghayouri M, Mehta R, Latifi K, Sweeney J, Jeong D, Ahmed A. Rare Abdominal Wall Metastasis following Curative Resection of Gastric Cancer: What Can Be Learned from the Use of Percutaneous Catheters?. Case Rep Oncol Med. 2020 May.2020:3738798. Pubmedid: 32509367. Pmcid: PMC7244962.
Thomas KL, Jeong D, Montilla-Soler J, Feuerlein S. The role of diagnostic imaging in the primary testicular cancer: initial staging, response assessment and surveillance. Transl Androl Urol. 2020 Jan.9(Suppl 1):S3-S13. Pubmedid: 32055480. Pmcid: PMC6995841.
Mishra A, Bigam KD, Extermann M, Faramand R, Thomas K, Pidala JA, Baracos VE. Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients. J Cachexia Sarcopenia Muscle. 2020 Dec.11(6):1570-1579. Pubmedid: 32729255. Pmcid: PMC7749567.
Sephien A, Mousa MS, Bui MM, Kedar R, Thomas K. Leiomyosarcoma of the Inferior Vena Cava with Hepatic and Pulmonary Metastases: Case Report. J Radiol Case Rep. 2019 May.13(5):30-40. Pubmedid: 31558957. Pmcid: PMC6742446.
Luu C, Thapa R, Rose T, Woo K, Jeong D, Thomas K, Chen DT, Friedman M, Malafa MP, Hodul PJ. Identification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papillary mucinous neoplasm. Int J Surg. 2018 Oct.58:46-49. Pubmedid: 30218781. Pmcid: PMC7771269.
Karydis I, Gangi A, Wheater MJ, Choi J, Wilson I, Thomas K, Pearce N, Takhar A, Gupta S, Hardman D, Sileno S, Stedman B, Zager JS, Ottensmeier C. Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease. J Surg Oncol. 2018 May.117(6):1170-1178. Pubmedid: 29284076. Pmcid: PMC6033148.
Thomas KL, Gonzalez RJ, Henderson-Jackson E, Caracciolo JT. Paratesticular Liposarcoma Masquerading as an Inguinal Hernia. Urology. 2018 Mar.113:e5-e6. Pubmedid: 29203187.
Abbott AM, Doepker MP, Kim Y, Perez MC, Gandle C, Thomas KL, Choi J, Shridhar R, Zager JS. Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma. Am J Clin Oncol. 2018 Aug.41(8):747-753. Pubmedid: 28059929. Pmcid: PMC7771287.
Morse B, Jeong D, Thomas K, Diallo D, Strosberg JR. Magnetic Resonance Imaging of Neuroendocrine Tumor Hepatic Metastases: Does Hepatobiliary Phase Imaging Improve Lesion Conspicuity and Interobserver Agreement of Lesion Measurements?. Pancreas. 2017 Oct.46(9):1219-1224. Pubmedid: 28902795.
Thomas K, Spiess P, Caracciolo JT. A report of two deep-seated noncutaneous penile tumors: more than meets the eye. Radiol Case Rep. 2017 Dec.12(4):726-730. Pubmedid: 29484058. Pmcid: PMC5823293.
Gage KL, Thomas K, Jeong D, Stallworth DG, Arrington JA. Multimodal Imaging of Head and Neck Squamous Cell Carcinoma. Cancer Control. 2017 Apr.24(2):172-179. Pubmedid: 28441371.
Thomas KL, Henderson-Jackson E, Caracciolo JT. Test yourself: right thigh mass. Skeletal Radiol. 2015 Aug.44(8):1151-1152. Pubmedid: 25669940.
Thomas KL, Henderson-Jackson E, Caracciolo JT. Test yourself: answer - deep benign fibrous histiocytoma. Skeletal Radiol. 2015 Aug.44(8):1151-2, 1209. Pubmedid: 25680331.
Creelan B, Thomas K, Massis K, Davis RM. Splenic arterial embolization for idiopathic warm auto-immune haemolytic anaemia. Brit J Haematol. 2013 Apr.161(1):2. Pubmedid: 23294152.
The Provider Rating is an average of all responses to specific care provider-related
questions from our nationally-recognized
Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive
different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our
Patient Satisfaction Survey . The comments are submitted by patients
and reflect their views and opinions. Patients are de-identified for confidentiality and
We post both positive and negative comments from the surveys. We do not post comments
that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may
risk the privacy of our patients.
A “[…]” in the comments below indicates de-identified patient information or comments that
are unrelated to the patient’s experience with the visit to the provider, such as
comments related to another provider, about the survey itself, or otherwise completely
Not all providers will have a star rating or comments. In order to ensure accuracy of our
ratings, we only display ratings for providers who have a minimum of 30 completed from
the previous 12 months.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey
Patient Satisfaction Survey. If a provider does not have ratings or comments listed it
can be for several reasons, including:
The provider has not yet received the minimum number of patient satisfaction surveys
to be eligible for display. We require a minimum of 30 surveys before we post
results to ensure that the rating is statistically reliable and a true reflection of
He or she may be a researcher or other type of provider that does not see patients.
The provider practices in a specialty or office that does not use the specified
surveys currently used for these ratings.
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate buttonbelow. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub